Skip to content

GYNEMIK

Active
Private limited companyfounded 20251 yr activeItterbeekse Laan 95, 1070 Anderlecht, BelgiumKBO/BCE: BE 1023.669.605
Summary

The computed 12-month bankruptcy probability of GYNEMIK is 17.0% (high). The 2025 annual accounts show equity of €39,193 and a net result of €38,193. The company has been active since 2025 and the Belgian State Gazette contains no insolvency signals. The CBE does carry 2 administrative register entries (see administrative flags).

Checked score

Score 2025
44 / 100
Weak
A high bankruptcy probability caps the score. Every signal that weighs is under Signals.
Axes
Profitability100
Solvency100
Growth-
Track record51
Bankruptcy probability, 12 months
17.0% High
0%0.5%1.5%4%10%≥ 25%
Credit up to €1,500 at 30 days only on tighter terms
Liquidity ample (current ratio 15.8; short-term debt: 5.4% and cash: 5.1% of total assets), and 5.4% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Eight signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Recent warning signals
The last 24 months brought warning signals in the Staatsblad or the KBO, and those often pile up before a bankruptcy.
Belgian State Gazette
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 1 year 0 10 y
raises risk · Ex-officio strike-off
The KBO struck this company off ex officio, which points to unmet obligations and often precedes a bankruptcy.
KBO publications
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
94.6%
Return on assets
92.2%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-08-2026, 28 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 1 filing
Deviation from the deadline
2025
28 d late
← before the deadline after the deadline →
raises risk · Administrative warnings in the KBO publications
2 publications by the FPS Economy about this company, such as a strike-off for address, accounts or UBO, or their withdrawal.
KBO publications
Publications
UBO non-compliance×2

History

On 23 May 2025, GYNEMIK was incorporated as a Private limited company.1 The company has filed annual accounts once, for fiscal year 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2025

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, abbreviated schema

Equity
€39,193
Total assets
€41,411
Net result
€38,193
Working capital
€32,821

Turnover and EBIT margin not published: the abbreviated schema does not require them.

Balance-sheet composition
Assets €41,411
Fixed assets €6,373
Current assets €35,039
Equity and liabilities €41,411
Equity €39,193
Debt €2,218
Debt finances 5.4% of the balance-sheet total.
Key figures and ratios
2025 value
EBITDA
€58,970
Cash flow
€38,951
Current ratio
15.80
Debt to equity
0.06
ROE
97.4%
ROA
92.2%
Interest coverage
2990.38
Debt ≤ 1 year
€2,218
Income taxes
€20,000

Peer companies

Historical observation

Of the 11,280 companies that looked in July 2024 the way this one looks now, 0.7% went bankrupt within 24 months and 97% are still going.

  • Micro
  • under 2 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.7% went bankrupt
2.6% stopped otherwise
97% still going

For this company itself Checked computes a higher bankruptcy probability: 17.0% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,340 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 11,280 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 · 27 lines
Balance sheet Code2025
Assets
Total assets20/58€41,411
Fixed assets21/28€6,373
Tangible fixed assets22/27€6,373
Plant, machinery and equipment23€3,042
Furniture and vehicles24€3,331
Current assets29/58€35,039
Amounts receivable within one year40/41€32,946
Other amounts receivable41€32,946
Cash at bank and in hand54/58€2,093
Equity and liabilities
Total equity and liabilities10/49€41,411
Equity10/15€39,193
Contributions10/11€1,000
Profit (loss) carried forward14€38,193
Amounts payable17/49€2,218
Amounts payable within one year42/48€2,218
Trade debts44€2,218
Suppliers440/4€2,218
Income statement Code2025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€757
Gross operating margin9900€58,970
Operating profit (loss)9901€58,213
Financial charges65/66B€20
Recurring financial charges65€20
Profit (loss) for the period before taxes9903€58,193
Income taxes67/77€20,000
Profit (loss) for the period9904€38,193
Profit (loss) for the period to be appropriated9905€38,193
Appropriation of the result
Profit (loss) to be appropriated9906€38,193

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€757
Gross operating margin9900€58,970
Operating profit (loss)9901€58,213
Financial charges65/66B€20
Recurring financial charges65€20
Profit (loss) for the period before taxes9903€58,193
Income taxes67/77€20,000
Profit (loss) for the period9904€38,193
Profit (loss) for the period to be appropriated9905€38,193
Line2025
Assets
Total assets20/58€41,411
Fixed assets21/28€6,373
Tangible fixed assets22/27€6,373
Plant, machinery and equipment23€3,042
Furniture and vehicles24€3,331
Current assets29/58€35,039
Amounts receivable within one year40/41€32,946
Other amounts receivable41€32,946
Cash at bank and in hand54/58€2,093
Equity and liabilities
Total equity and liabilities10/49€41,411
Equity10/15€39,193
Contributions10/11€1,000
Profit (loss) carried forward14€38,193
Amounts payable17/49€2,218
Amounts payable within one year42/48€2,218
Trade debts44€2,218
Suppliers440/4€2,218
Line2025
Profit (loss) for the period9904€38,193
+ Depreciation and write-downs630€757
Operating cash flow (approximation)€38,951

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2026
28-08
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema · 28 days late
12-01
KBO administration UBO non-compliance
event 22-12-2025
2025
05-12
KBO administration UBO non-compliance
event 22-11-2025
SignalNBB filing
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Anderlecht · 1 establishment unit since 2025
seat establishment The establishment unit on the map
Ground area
658 m²
Building footprint
217 m²
Volume, LiDAR
2,471 m³
Parcel 21001A0346/00T003, Brussels · tallest building 13.9 m, ±4 floors. Linked by address, not a title deed.
3 companies at this address See who is registered here
1 establishment unit
Itterbeekse Laan 95, 1070 Anderlecht
Specialist medical practice
since 20252.377.213.048
1 parcel
Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21001A0346/00T003 Brussels 658 m² 1 · 217 m² 13.9 m · 4 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Identification & contact

Identification
Legal formPrivate limited company
Founded23-05-2025
Fiscal year end31-12
E-invoicing
Reachable via Peppol
Peppol ID 0208:1023669605
Also 9925:BE1023669605
Registered 26-06-2026

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 30 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.